Bright Future Today
  • Investing
  • Business
  • World News
  • Stock
Investing

Investor Webinar – 3pm AEST Tuesday 2 July

by July 1, 2024
July 1, 2024

Radiopharm Theranostics (ASX:RAD, “Radiopharm” or the “Company”), a clinical-stage biopharmaceutical company focused on developing innovative oncology radiopharmaceuticals for areas of high unmet medical need, is pleased to announce that CEO and Managing Director Riccardo Canevari and Executive Chairman Paul Hopper will conduct an investor webinar to provide an update following announcement of the Company’s $70 million capital raising.

When: 3pm AEST, Tuesday 2 July 2024

Register at: https://us02web.zoom.us/webinar/register/WN_wcKESuixTf2e5TRIwVAW_Q

Upon registering attendees will receive an email containing information about joining the webinar. A recording will be available at the above link soon after the conclusion of the live session, with the replay to also be made available via Radiopharm’s website and social media channels.

Questions can be sent in advance of the webinar to matt@nwrcommunications.com.au.

About Radiopharm Theranostics

Radiopharm Theranostics is a clinical stage radiotherapeutics company developing a world-class platform of innovative radiopharmaceutical products for diagnostic and therapeutic applications in areas of high unmet medical need. Radiopharm has been listed on ASX (RAD) since November 2021. The company has a pipeline of distinct and highly differentiated platform technologies spanning peptides, small molecules and monoclonal antibodies for use in cancer, in pre-clinical and clinical stages of development from some of the world’s leading universities and institutes. The pipeline has been built based on the potential to be first-to-market or best-in-class. Learn more at Radiopharmtheranostics.com.

Click here for the full ASX Release

This post appeared first on investingnews.com
previous post
Trump advisers seek to simplify Republican Party platform, memo says
next post
Strategy for Cuban Mining Joint Venture

You may also like

Triumph Gold: Multi-million-ounce, District-scale Gold Assets in the...

May 7, 2025

Joe Cavatoni: Gold’s Record Run No Surprise, Here’s...

May 7, 2025

Update – Blackstone Merger to Acquire Copper Gold...

May 7, 2025

5 Biggest Pharmaceutical ETFs in 2025

May 7, 2025

Copper Crunch: China’s Stockpiles Depleting, US Demand Rising

May 7, 2025

Jindalee Lithium Limited (ASX: JLL) – Trading Halt

July 4, 2024

First Diamond Drilling Results at Ricciardo Deliver High-Grade...

July 4, 2024

From EVs to Energy: Experts Explore Cleantech Investment...

July 4, 2024

Top 3 Canadian Biotech Stocks of 2024

July 4, 2024

Jindalee Lithium Limited (ASX: JLL) – Reinstatement to...

July 4, 2024

    Join our mailing list to get access to special deals, promotions, and insider information. Your exclusive benefits await! Enjoy personalized recommendations, first dibs on sales, and members-only content that makes you feel like a true VIP. Sign up now and start saving!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Recent Posts

    • Israeli military issues unprecedented evacuation warning for Yemen’s international airport

      May 7, 2025
    • India launches military operation against Pakistan, explosions heard

      May 7, 2025
    • Netanyahu chooses war – and his political survival – as Israelis demand hostage deal

      May 7, 2025
    • Israeli airstrike on central Gaza school compound housing displaced people kills 22, as military operation intensifies

      May 7, 2025
    • India and Pakistan are on the brink of all-out war. Here’s what we know

      May 7, 2025
    • About us
    • Contacts
    • Privacy Policy
    • Terms and Conditions
    • Email Whitelisting

    Copyright © 2025 brightfuturetoday.com | All Rights Reserved

    Bright Future Today
    • Investing
    • Business
    • World News
    • Stock